Validity of Real World Evidence and Regulatory Acceptability
As outlined in PDUFA VI, the FDA committed to hold public workshops and initiate and fund activities to address concerns and considerations in the use of Real World Data (RWD) for regulatory decision making. By the end of 2021, it is expected that the FDA will issue draft guidance on the use of Real World … Continued
